YONGIN, KOREA— Global Neurotech (GNT) Pharma Co., Ltd., a privately held company based in Yongin city, South Korea is pleased to announce a strategic relationship with Toyota Tsusho Corporation (TTC) based in Tokyo. 

 

TTC will represent GNT Pharma exclusively in Japan in promoting its products and technologies in the area of first-in-class new drug discovery for neurological and inflammatory diseases. 

 

“With the changing business model for drug discovery, we are happy to appoint TTC as our exclusive representative in Japan to help us grow our Japanese customer base. As TTC's plan looks to expand its revenue related to non-automotive business, we are pleased to help it grow in the life sciences and healthcare business globally,” stated Dr. Byoung Joo Gwag, CEO and R&D head of GNT Pharma. 

 

According to TTC, the collaboration with GNT will enable TTC to provide more customer-oriented business to Japanese leading pharmaceutical manufacturers through the domestic network which TTC has established so far.